G
GFBiochemicals
Produces levulinic acid at commercial scale directly from biomass
About GFBiochemicals
A biochemical company that produces levulinic acid, a bio-based building block for specialty chemicals and materials, from biomass at a commercial scale.
GFBiochemicals' proprietary technology allows it to replace petroleum-based products, contributing to a more sustainable and circular economy. The company operates a production plant in Caserta, Italy, and has a presence in the Netherlands and the US through its acquisition of Segetis.
The company's mission is to end chemical pollution by providing businesses with bio-based alternatives for everyday products. GFBiochemicals recently raised €15 million in a Series A funding round to advance this mission.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Paris, France
- Employees
- 41
- Open positions
- 1
- Dealroom signal
- 80.3/100
- Sector
- Biotechnology, Additive Manufacturing, Biofuel, Sustainable Development Goals, Climate Tech, Clean Industry, Hard Tech, observatoire greentech, observatoire industrial tech
- Technology
- Hardware
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Feb 2016
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2022 | $17M | $66M | Sparta Capital · Sofinnova Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for GFBiochemicals is 2.4K monthly website visits, up 203.8% over the last three months. GFBiochemicals's team grew 5.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Sofinnova Partners
Sparta Capital
Other known investors1 additional known investor
- GSGuillaume Sarlat
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about GFBiochemicals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GFBiochemicals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








